The next generation of cancer management

References

1. 1.↵
   2. Ten Bosch JR,
   3. Grody WW.

   Keeping up with the next Generation: massively parallel sequencing in clinical diagnostics. J Mol Diagn. 2008; 10: 484–92.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   2. Aziz N,
   3. Zhao Q,
   4. Bry L,
   5. Driscoll DK,
   6. Funke B,
   7. Gibson JS, et al.

   College of American pathologists' laboratory standards for nextgeneration sequencing clinical tests. Arch Pathol Lab Med. 2015; 139: 481–93.

   OpenUrlCrossRefPubMed
3. 3.↵
   2. Lee H,
   3. Deignan JL,
   4. Dorrani N,
   5. Strom SP,
   6. Kantarci S,
   7. QuinteroRivera F, et al.

   Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014; 312: 1880–7.

   OpenUrlCrossRefPubMed
4. 4.↵
   2. Luthra R,
   3. Chen H,
   4. Roy-Chowdhuri S,
   5. Singh RR.

   Next-Generation sequencing in clinical molecular diagnostics of cancer: advantages and challenges. Cancers (Basel). 2015; 7: 2023–36.

   OpenUrl
5. 5.↵
   2. Dietel M,
   3. Jöhrens K,
   4. Laffert MV,
   5. Hummel M,
   6. Bläker H,
   7. Pfitzner BM, et al.

   A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focusing on clinical relevance. Cancer Gene Ther. 2015; 22: 417–30.

   OpenUrlPubMed
6. 6.↵
   2. Clarke AJ.

   Managing the ethical challenges of next-generation sequencing in genomic medicine. Br Med Bull. 2014; 111: 17–30.

   OpenUrlCrossRefPubMed
7. 7.↵
   2. Williams ES,
   3. Hegde M.

   Implementing genomic medicine in pathology. Adv Anat Pathol. 2013; 20: 238–44.

   OpenUrl